Ireland
--:--IST
Recruiting Not applicable

Pulmonary Functions in Sickle Cell Disease: Response to Acu-TENS

NCT06757829 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-12-15
Last updated
2025-01-03

Condition(s) studied

Sickle Cell Disease

Investigational drug(s) / intervention(s)

inspiratory muscle training and acupucnture like transcutanoeus electrical nerve stimulationinspiratory muscle training

inspiratory muscle training and acupucnture like transcutanoeus electrical nerve stimulation: sickle cell disease patients whose number will be 20 patients will be trained with IMT (threshold inspiratory muscle training) and treated with AC-tens. The number of sessions per week will be three sessions for IMT or AC-tens for 12 weeks. the IMT will be performed for six sets of respiratory training cycles and the set will contain 10 respiratory cycles. Also the session of AC-tens will be 45 minute on bilateral Ex-B1 acupoint. the parameters of AC-tens will be four hertz and 200 microsecond pulse duration.

inspiratory muscle training: sickle cell disease patients whose number will be 20 patients who will trained with IMT (threshold inspiratory muscle training). The number of sessions per week will be three sessions for IMT for 12 weeks. the IMT will be performed for six sets of respiratory training cycles and the set will contain 10 respiratory cycles.

Study summary

pulmonary complications are common in sickle cell disease patients. Respiratory training using inspiratory muscle trainer (IMT) is usually a good choice to improve these complications. Recently, acupuncture like transcutaneous electrical nerve stimulation (AC-tens) may also improve these complications.

Eligibility

Sex
ALL
Min age
20 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * sickle cell disease patients * non obese patients Exclusion Criteria: * patients with any systemic or chest or renal or hepatic or neurological diseases * women with lactation or pregnancy * patients atacks of vasoocclusive crisis

Primary outcome measure(s)

  • FEV1/FVC ratio — it will be assessed after12 weeks
    will be measured by spirometry

Trial sites (1)

FacilityCityRegionStatus
faculty of physical therapy Cairo university Dokki Giza Governorate Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06757829 on ClinicalTrials.gov ↗ ← All trials in Egypt